Literature DB >> 19874326

Perinatal exposure to endotoxin and the development of eczema during the first 6 years of life.

C-M Chen1, S Sausenthaler, W Bischof, O Herbarth, M Borte, H Behrendt, U Krämer, H C Williams, H-E Wichmann, J Heinrich.   

Abstract

BACKGROUND: Previous studies have reported a protective association between high levels of exposure to endotoxin during infancy and the development of subsequent eczema within the first 6 months of life. AIM: To investigate the association between exposure in infancy to endotoxin from mattress dust and the development of eczema up to age of 6 years in 2166 children participating in the German Influences of Lifestyle-Related Factors on the Immune System and the Development of Allergies in Childhood (LISA) study, an ongoing population-based birth-cohort study.
METHODS: Endotoxin levels in house dust samples collected at 3 months after birth were quantified using the kinetic Limulus amebocyte lysate assay. Specific IgE antibodies to common food and aeroallergens were measured using radioallergosorbent test, fluorenzyme immunoassay (Pharmacia CAP system) when children were 2 and 6 years old. Information on eczema symptoms and physician-diagnosed eczema were collected at each follow-up using a questionnaire.
RESULTS: No association was found between endotoxin exposure from mattresses (the mattresses of each child and their parents were examined) during infancy and the development of eczema symptoms or doctor-diagnosed eczema by 6 years of age (OR = 1.1, 95% CI 0.5-2.3, and OR = 1.1, 95% CI 0.4-3.3, respectively). No association was found when children with only atopic eczema.
CONCLUSION: Endotoxin exposure during infancy is unlikely to have a large long-term effect on the development of eczema, especially the atopic form.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19874326     DOI: 10.1111/j.1365-2230.2009.03460.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  2 in total

1.  Improved exposure characterization with robotic (PIPER) sampling and association with children's respiratory symptoms, asthma and eczema.

Authors:  Maya Ramagopal; Zuocheng Wang; Kathleen Black; Marta Hernandez; Adam A Stambler; Osiloke H Emoekpere; Gediminas Mainelis; Stuart L Shalat
Journal:  J Expo Sci Environ Epidemiol       Date:  2014-05-07       Impact factor: 5.563

2.  Variants of the FADS1 FADS2 gene cluster, blood levels of polyunsaturated fatty acids and eczema in children within the first 2 years of life.

Authors:  Peter Rzehak; Carel Thijs; Marie Standl; Monique Mommers; Claudia Glaser; Eugène Jansen; Norman Klopp; Gerard H Koppelman; Paula Singmann; Dirkje S Postma; Stefanie Sausenthaler; Pieter C Dagnelie; Piet A van den Brandt; Berthold Koletzko; Joachim Heinrich
Journal:  PLoS One       Date:  2010-10-11       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.